| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,317,000 | 3,299,000 | 2,905,000 | 4,243,000 | | Cost of Revenue |
-
|
-
|
-
| 8,787,000 | | | Gross Profit | 3,317,000 | 3,299,000 | 2,905,000 | (4,544,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,453,000 | 2,633,000 | 2,381,000 | (5,143,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 80,000 | 80,000 | 82,000 | 124,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 784,000 | 586,000 | 442,000 | 475,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (97,000) | (18,000) | (16,000) | (101,000) | | Earnings Before Interest And Taxes | 361,000 | 545,000 | 393,000 | 348,000 | | Interest Expense | (218,000) | 106,000 | 112,000 | 92,000 | | Income Before Tax | 579,000 | 439,000 | 281,000 | 256,000 | | Income Tax Expense | 133,000 | 158,000 | 101,000 | 79,000 | | Minority Interest |
-
|
-
|
-
| (5,000) | | | | Net Income From Continuing Ops | 446,000 | 281,000 | 180,000 | 172,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 456,000 | 281,000 | 180,000 | 173,000 | | Preferred Stock And Other Adjustments | 7,000 | (4,000) | (3,000) |
-
| | | Net Income Applicable To Common Shares | $463,000 | $277,000 | $177,000 | $173,000 |
|
1.29% Nasdaq 0.00%
Income Statement
